Janssen Search
Search results
Peter Ronco
PETER RONCO HEAD GLOBAL DEVELOPMENT Peter Ronco is responsible for leading the Global Development organization in delivering the portfolio on time, within budget, and with robust quality while continuously improving to optimize efficiency and the patient ...
Taking action together to tackle TB
Taking Action Together to Tackle TB A week is a long time in politics, so the saying goes. In that case, 135 years must be an eternity in healthcare. On March 24, 1882, German physician Robert Koch presented a paper at a medical conference which ...
Lucinda Warren
LUCINDA WARREN VICE PRESIDENT BUSINESS DEVELOPMENT Lucinda (Cindy) Warren is Vice President, Business Development, Neuroscience, which includes scientific finding, licensing transactions, mergers, acquisition, out licensing and alliance management. With ...
Collaboration in Infectious Disease Research
Article Type: Infectious Diseases & Vaccines Our Partners in Infectious Diseases & Vaccines Our innovation is founded by our mission to discover and develop novel therapeutics and vaccines to treat and cure infectious diseases worldwide, ...
Sustainability – Green Chemistry
Product Stewardship Through the Lifecycle: Green Chemistry and Technology Yield Business and Environmental Benefits At Janssen, our purpose is to help people lead healthier, happier lives. To create a healthier future, we see an opportunity to create ...
Our Story
We focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives. Who We Are Who is Janssen? We’re more than 30,000 people working hard to prevent, treat, cure and ...
World Diabetes Day 2016
Janssen Set on Diabetes and Its Life-Threatening Complications Every six seconds someone dies from diabetes. In 2015, diabetes claimed the lives of 5 million people worldwide. As the number of people with diabetes grows, so will this death toll, unless ...
Janssen Clinical Innovation Challenge: Transforming (Long-Term Extension) Studies
Article Type: Other Janssen Clinical Innovation Challenge: Transforming (Long-Term Extension) Studies Janssen Clinical Innovation (JCI) is a team within Janssen Research & Development, LLC, leading efforts to develop and implement new approaches to ...
Commitment to Immunodermatology Newsroom
Welcome to the Johnson & Johnson Immunodermatology Newsroom! Below, please find the latest data, content, meeting news and leadership messages about our progress and commitment to developing transformational approaches and innovative medicines for ...
Automating Clinical Trials
Automating Clinical Trials Oct 26, 2017 Janssen develops digital tool to help automate clinical trials. Read the article in PM Live. Article Block Text: Janssen develops digital tool to help automate clinical trials. Read the article in PM Live. ...